; (iii) the implementation or effectiveness of any Federal law or regulation applied, enacted, or under consideration to address the coronavirus pandemic and prepare for future pandemics; (iv) the development of vaccines and treatments, and the development and implementation of vaccination policies for Federal employees and members of the armed forces; (v) the economic impact of the coronavirus pandemic and associated government response on individuals, communities, small businesses, health care providers, States, and local government entities; (vi) the societal impact of decisions to close schools, how the decisions were made and whether there is evidence of widespread learning loss or other negative effects as a result of these decisions; (vii) executive branch policies, deliberations, decisions, activities, and internal and external communications related to the coronavirus pandemic; (viii) the protection of whistleblowers who provide information about waste, fraud, abuse, or other improper activities related to the coronavirus pandemic